Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BSX - BOSTON SCIENTIFIC CORP


103.04
-0.460   -0.446%

Share volume: 6,325,520
Last Updated: Thu 30 Jan 2025 10:00:00 PM CET
Surgical and Medical Instrument Manufacturing : -0.22%

PREVIOUS CLOSE
CHG
CHG%

$103.50
0.33
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
54%
Profitability 44%
Dept financing 47%
Liquidity 17%
Performance 76%
Company vs Stock growth
vs
Performance
5 Days
0.75%
1 Month
15.36%
3 Months
22.64%
6 Months
39.47%
1 Year
62.88%
2 Year
122.79%
Key data
Stock price
$103.04
P/E Ratio 
68.86
DAY RANGE
$102.83 - $104.25
EPS 
$1.25
52 WEEK RANGE
$64.08 - $104.25
52 WEEK CHANGE
$60.07
MARKET CAP 
123.406 B
YIELD 
N/A
SHARES OUTSTANDING 
1.473 B
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.66
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$6,414,558
AVERAGE 30 VOLUME 
$5,876,831
Company detail
CEO: Michael F. Mahoney
Region: US
Website: bostonscientific.com
Employees: 45,000
IPO year: 1992
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions.

Recent news